[Home]
[Full version]
Genetics May Affect How Older Adults Respond to Exercise
Aug 10 ,General Science
New research suggests why some older adults who exercise have better physical function than others. Surprisingly, researchers found that an enzyme involved in blood pressure regulation may also influence how the body responds to exercise. The findings, by researchers at Wake Forest University School of Medicine and colleagues, are reported today in the Journal of the American Medical Association.
“Our results reinforce the importance of exercise, but also may explain a mechanism for why it seems to benefit some individuals more than others,” said Stephen Kritchevsky, Ph.D., professor of gerontology at Wake Forest, who led the study.
The study is the first to show that a gene that controls levels of angiotensin converting enzyme (ACE) in the body may be associated with physical function in older adults.
The researchers found that older exercisers who inherited a gene combination associated with the lowest ACE production were 45 percent more likely to develop difficulties with climbing stairs or walking a quarter-mile than exercisers with gene combinations associated with higher levels of ACE.
“Overall, ACE genotype seems to be associated with how well activity helps preserve function,” said Kritchevsky. “This finding may offer new opportunities to explore treatments to help older adults maintain their function.”
The results are from the ongoing Health Aging and Body Composition Cohort Study, conducted in the metropolitan areas of Memphis, Tenn., and Pittsburgh, Pa. The study involves 3,075 well-functioning, community-dwelling adults ages 70 through 79. Participants were enrolled in 1997 and 1998.
The current data are from 2,966 participants who were followed for up to 4.1 years. About a third (31.3 percent) of the group was active, burning more than 1,000 calories a week in exercise; the others were inactive. The researchers found that the exercisers were significantly less likely (33 percent) to report mobility problems than the non-exercisers.
More than a third of the United States population who are 70 and older report having difficulty walking a quarter-mile or climbing 10 stairs. Previous research has shown that these mobility difficulties often proceed to physical disability. Older adults reporting these difficulties are at four times the risk of entering a nursing home and three times the risk of dying over a two-year period compared with those reporting no difficulty.
“Research has consistently found that exercise is associated with lower risk for physical decline,” said Kritchevsky. “But despite exercise’s benefit, individual responses vary and our current findings about the ACE genotype may help explain why.”
The same ACE gene combination associated with better function in exercising older adults has been associated with superior muscle strength and power in young elite athletes. The current study was designed to test whether ACE production also affects physical function in older exercisers.
The gene that controls ACE production can be inherited in three different combinations. Only about 19 percent of study participants had the combination associated with lower ACE production and did not benefit as much from exercise as others. However, they still did better than those who didn’t exercise.
“The results underscore the need to learn more about how the ACE system influences human health,” Kritchevsky said.
Source: Wake Forest University School of Medicine
Related stories:
Why disability rates are dropping among older Americans
Better medical care and more education—not positive life-style changes—are the major reasons for a decades-long decline in disability rates among older Americans. That's according to a new study funded by the National Institute on Aging that provides one of the first comprehensive looks at the factors fueling the welcome trend.
Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke
An international study led by Canadian researchers has found that telmisartan, a medication used to lower blood pressure, reduced the outcome of cardiovascular death, heart attack or stroke in people who are unable to tolerate a widely available and effective standard treatment.
Researchers devise means to create blood by identifying earliest stem cells
Johns Hopkins researchers have discovered the earliest form of human blood stem cells and deciphered the mechanism by which these embryonic stem cells replicate and grow. They also found a surprising biological marker that pinpoints these stem cells, which serve as the progenitors for red blood cells and lymphocytes.
Sweets make young horses harder to train in Montana State study
Young horses may be easier to train if they temporarily lay off the sweets, says a Montana State University study where two-year-olds wore pedometers, wrist watches and Ace bandages.
Southern Ocean seals dive deep for climate data
(PhysOrg.com) -- Elephant seals are helping scientists overcome a critical blind-spot in their ability to detect change in Southern Ocean circulation and sea ice production and its influence on global climate.
Pregnancy associated with increased risk of heart attack
Although acute myocardial infarction (AMI) is rare in women of child-bearing age, pregnancy can increase a woman's risk of heart attack 3- to 4-fold, according to a study published in the July 15, 2008, issue of the
Journal of the American College of Cardiology. Since women today may delay having children until later in life, and advances in reproductive medicine enable older women to conceive, the occurrence of AMI associated with pregnancy is expected to increase.
Solar Shield Experiment Aims to Keep the Power On
When you flip a light switch to illuminate the pages of your favorite book or reach into your refrigerator for that last piece of key lime pie, you expect the electric current coursing through the outlets to power everything from your lights to your nifty new big-screen television. When the power goes out, it can be more than just an inconvenience.
Drug treatment for Marfan syndrome looks promising
A small study in 18 pattients assessing the effectiveness of the drug losartan for treating Marfan syndrome in children has yielded encouraging results. Reporting in the June 26 issue of
The New England Journal of Medicine, Johns Hopkins researchers showed that losartan-a compound used for years to treat high blood pressure-slowed the enlargement of the aorta, the most life-threatening defect associated with Marfan syndrome.
[Home]
[Full version]